Tenaya Therapeutics gets grant for compound for treating diseases by inhibiting HDAC6 activity

1d ago, source: Pharmaceutical Technology

Discover the groundbreaking patent by Tenaya Therapeutics Inc for compounds inhibiting HDAC6 activity, paving the way for potential disease treatments. Explore the detailed chemical formulas and ...

Tenaya Therapeutics Inc TNYA

3d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Institutions own 33% of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) shares but private equity firms control 44% of the company

5d ago, source:

Tenaya Therapeutics' significant private equity firms ownership suggests that the key decisions are influenced by ...

Tenaya Therapeutics Secures $50 Million in Share Sale

2mon ago, source: TipRanks on MSN

Tenaya Therapeutics, Inc. has struck a deal with underwriters, led by Leerink Partners LLC and Cowen and Company, LLC, to ...

Tenaya Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

1mon ago, source: Business Insider

March 18, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies ...

Tenaya Therapeutics’ Strategic Advantages in Cardiovascular Genetic Medicine Garner Buy Rating

14d ago, source: Business Insider

Begin your TipRanks Premium journey today. Tenaya Therapeutics (TNYA) Company Description: Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and ...

Tenaya Therapeutics, Inc.: Tenaya Therapeutics Announces Publication of TN-401 Gene Therapy Preclinical Data in Nature Communications Medicine

1mon ago, source: Finanznachrichten

March 18, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies ...

TNYA Tenaya Therapeutics, Inc.

12d ago, source: Seeking Alpha

Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through gene editing, cellular ...

Tenaya Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

1mon ago, source: Stockhouse

March 18, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that ...

Tenaya Therapeutics Inc TNYA

28d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Tenaya Therapeutics, Inc.: Tenaya Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

1mon ago, source: Finanznachrichten

March 18, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies ...

Tenaya Therapeutics, Inc. (TNYA)

1y ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...